Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
there will be small buys available to PIs but try buying £20k worth you will probably find your in a queue .But this gives an illusion that there's lots about together with price fluctuation its a recipe to encourage people into selling and hoping to buy back cheaper.
Strong support here
https://www.statnews.com/2020/10/15/thank-this-ebola-fighting-african-doctor-muyembe-tamfum-for-monoclonal-antibody-treatments/
The trades you see today imo are to keep you one step behind the real price that's why the big trades are showing days later and they are not from PIs. So last weeks rise was to encourage you to sell and now we are in the reversal again without knowing what the real price is as the manipulation continues and if you sell a decent amount there's a chance you will struggle to buy back the same amount cheaper hence the small trades showing on the day.
Looks like monoclonal antibodies treatment could be the saviour way before any safe vaccine is available
https://www.dailymail.co.uk/news/article-8833259/J-J-COVID-19-vaccine-study-paused-unexplained-illness-participant-Stat-News.html
im not buying the price decline on Nasdaq its more likely they are working with our MMs to manipulate the price due to the huge potential here.
Relatively small trades being displayed and could be a sign of not that many free shares being offered to PI's so hold on to your s
A good explanation about monoclonal antibodies potential and the revenues they can generate https://wellcome.org/news/what-are-monoclonal-antibodies-can-they-treat-covid-19
https://www.dailymail.co.uk/news/article-8801003/Fears-mount-global-shortage-coronavirus-drug-remdesivir-bought-world-supply.html. Looking good for Foralumab patent
From Tiziana website Remdesivir is mentioned but as an alternative drug but still could be delivered using its technology
Tiziana Life Sciences intends to accelerate the development of hand-held nebulizer inhalation technology to deliver stable aerosols of TZLS-501 (anti-IL-6R mAb) and potentially other antiviral drugs such as remdesivir directly to lungs to treat COVID-19 by Q2 2021.Tiziana believes TZLS-501 (anti-IL6R mAb) combined with this newly introduced inhalation technology may rapidly inhibit inflammation in lungs and in combination with intravenous administration may deplete circulating levels of IL-6 and potentially halt progression of COVID-19-mediated lung damage and death.
you can only buy what's available but for what price ? We have been waiting for this news but so have the MMs who been frightening PIs and are now loaded up and they won't give them away cheaply as there's a clear market all the way to the cut off date
From when they announced in their RNS there will be no more placings that's when IMO PIs became targets. Institution Investors had their own private discussions with the board and have their own agenda based on what was discussed. So with the price decline to date there has been no mention about this put to them from Proactive or Redchips recent interviews and no urgency from the board to reassure shareholders. Looks to me that we have to accept we are the weak targets in all this and if you can just sit tight the bounce will come at some point.
In these update videos there's no questions being raised about the current share price decline . Its like this doesn't seem to be a major concern to them so maybe there's news out there that will correct it.
I think the company stating their intention not to issue more shares once they move to the main market could be why this is being held back as there's can't be that many available. Looks like a well planned strategy against PIs but good news is good news and a drop in the share price can't change that and we just have to be patient to reap the rewards just at a later date.
This is very important news in the companys decision to apply to join the main market and attract international investors as we need all relevant pieces of the bigger picture in place so we all will benefit more in the long term. IMO the MMs know the importance of this news and how the companys accelerated plan is coming together but if the price doesn't rise as rapidly like some are quoting it doesn't mean any less in the significance of the news and we will have our day.
Unfortunately I can't see them responding with anything significant as in reality we are just small fry compared to Institutional Investors who have just purchased another £57m worth and im sure they are patient enough to allow the company to carry out their plan of action with a long term goal in view.
Defo institutions are loading up and large trades are showing up a day late and after hours to keep PIs guessing and scare them to sell.
The Q&A session with RedChip right at the end they said they were going to take questions from Institution Investors but the session ended so we are unaware of what was discussed so IMO best sit tight as all this looks pre planned to me
Hopefully with the new shares admission the MMs can drive this back up now
i'm expecting some big news to justify their reasoning to move to the main market to attract international investors